Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial.
Authors: Juul SE; University of Washington, Seattle., Voldal E; University of Washington, Seattle., Comstock BA; University of Washington, Seattle., Massaro AN; Children's National Health Systems, Washington, DC., Bammler TK; University of Washington, Seattle., Mayock DE; University of Washington, Seattle., Heagerty PJ; University of Washington, Seattle., Wu YW; University of California, San Francisco., Numis AL; University of California, San Francisco.
Corporate Authors: HEAL consortium
Source: JAMA network open [JAMA Netw Open] 2023 Jul 03; Vol. 6 (7), pp. e2322131. Date of Electronic Publication: 2023 Jul 03.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2574-3805
DOI:10.1001/jamanetworkopen.2023.22131